Clarity Pharmaceuticals Ltd. earnings per share and revenue

CLRPF earnings per share for the last semiannual are -0.04 USD whereas the estimation was -0.03 USD which accounts for -14.48% surprise. Company revenue for the same period amounts to 4.06 M USD despite the estimated figure of 3.29 M USD. Estimated earnings per share for the next semiannual are -0.05 USD, and revenue is expected to reach 7.71 M USD. Also watch annual changes over time to get a bigger picture of CLRPF earnings per share and revenue dynamics.